156 related articles for article (PubMed ID: 20801035)
1. Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A.
Lee DY; Yang L; Xu W; Deng G; Guo L; Liu-Chen LY
Bioorg Med Chem Lett; 2010 Oct; 20(19):5749-52. PubMed ID: 20801035
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of C-12 triazole and oxadiazole analogs of salvinorin A.
Yang L; Xu W; Chen F; Liu-Chen LY; Ma Z; Lee DY
Bioorg Med Chem Lett; 2009 Mar; 19(5):1301-4. PubMed ID: 19211245
[TBL] [Abstract][Full Text] [Related]
3. Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor.
Béguin C; Duncan KK; Munro TA; Ho DM; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
Bioorg Med Chem; 2009 Feb; 17(3):1370-80. PubMed ID: 19147366
[TBL] [Abstract][Full Text] [Related]
4. Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.
Béguin C; Potuzak J; Xu W; Liu-Chen LY; Streicher JM; Groer CE; Bohn LM; Carlezon WA; Cohen BM
Bioorg Med Chem Lett; 2012 Jan; 22(2):1023-6. PubMed ID: 22204910
[TBL] [Abstract][Full Text] [Related]
5. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
[TBL] [Abstract][Full Text] [Related]
6. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
7. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.
Simpson DS; Lovell KM; Lozama A; Han N; Day VW; Dersch CM; Rothman RB; Prisinzano TE
Org Biomol Chem; 2009 Sep; 7(18):3748-56. PubMed ID: 19707679
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A.
Wang Y; Chen Y; Xu W; Lee DY; Ma Z; Rawls SM; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2008 Mar; 324(3):1073-83. PubMed ID: 18089845
[TBL] [Abstract][Full Text] [Related]
9. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.
Simpson DS; Katavic PL; Lozama A; Harding WW; Parrish D; Deschamps JR; Dersch CM; Partilla JS; Rothman RB; Navarro H; Prisinzano TE
J Med Chem; 2007 Jul; 50(15):3596-603. PubMed ID: 17580847
[TBL] [Abstract][Full Text] [Related]
10. Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.
Polepally PR; Huben K; Vardy E; Setola V; Mosier PD; Roth BL; Zjawiony JK
Eur J Med Chem; 2014 Oct; 85():818-29. PubMed ID: 25193297
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids.
Fichna J; Lewellyn K; Yan F; Roth BL; Zjawiony JK
Bioorg Med Chem Lett; 2011 Jan; 21(1):160-3. PubMed ID: 21115248
[TBL] [Abstract][Full Text] [Related]
12. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
Munro TA; Rizzacasa MA; Roth BL; Toth BA; Yan F
J Med Chem; 2005 Jan; 48(2):345-8. PubMed ID: 15658846
[TBL] [Abstract][Full Text] [Related]
13. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
Lee DY; He M; Liu-Chen LY; Wang Y; Li JG; Xu W; Ma Z; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2006 Nov; 16(21):5498-502. PubMed ID: 16945525
[TBL] [Abstract][Full Text] [Related]
15. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
[TBL] [Abstract][Full Text] [Related]
16. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
18. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.
Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Gilmour B; Navarro H; Rothman RB; Prisinzano TE
J Nat Prod; 2006 Jan; 69(1):107-12. PubMed ID: 16441078
[TBL] [Abstract][Full Text] [Related]
19. Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.
Kivell BM; Ewald AW; Prisinzano TE
Adv Pharmacol; 2014; 69():481-511. PubMed ID: 24484985
[TBL] [Abstract][Full Text] [Related]
20. Chemical syntheses of the salvinorin chemotype of KOR agonist.
Hill SJ; Brion AUCM; Shenvi RA
Nat Prod Rep; 2020 Nov; 37(11):1478-1496. PubMed ID: 32808003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]